1ST Source Bank’s AstraZeneca AZN Stock Holding History

1ST Source Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Buy	+1,311	New	+$247K	0.01%	266
2026 Q1	–	Sell	-1,311	Closed	-$241K	–	288
2025 Q4	$241K	Hold	1,311	–	–	0.01%	259
2025 Q3	$201K	Buy	+1,311	New	+$198K	0.01%	265
2023 Q2	–	Sell	-1,493	Closed	-$207K	–	245
2023 Q1	$207K	Buy	+1,493	New	+$201K	0.01%	241
2022 Q2	–	Sell	-1,666	Closed	-$221K	–	247
2022 Q1	$221K	Buy	+1,666	New	+$200K	0.01%	253

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

1ST Source Bank's AZN Position: Q2 2026 in Review

1ST Source Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 1,311 shares worth $249K. The stake represents 0.01% of the portfolio and ranks #266 among its holdings. This is a return to the name: 1ST Source Bank previously reported a position in AZN as recently as Q4 2025.

1ST Source Bank first reported a position in AZN in Q1 2022 and has held it in 5 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

1ST Source Bank held 1,311 shares of AstraZeneca worth $249K as of Q2 2026.
AstraZeneca was a new 1ST Source Bank position in Q2 2026.
AstraZeneca made up 0.01% of 1ST Source Bank's portfolio in Q2 2026, its #266 holding.
1ST Source Bank first reported a position in AstraZeneca in Q1 2022 and has held it in 5 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on 1ST Source Bank's 13F filing for Q2 2026, filed 6 Aug 2026.